Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
van Moort I, Preijers T, Bukkems LH, Hazendonk HCAM, van der Bom JG, Laros-van Gorkom BAP, Beckers EAM, Nieuwenhuizen L, van der Meer FJM, Ypma P, Coppens M, Fijnvandraat K, Schutgens REG, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH; OPTI-CLOT study group. van Moort I, et al. Among authors: fijnvandraat k. Lancet Haematol. 2021 Jul;8(7):e492-e502. doi: 10.1016/S2352-3026(21)00135-6. Lancet Haematol. 2021. PMID: 34171280 Clinical Trial.
Health-related quality of life among adult patients with moderate and severe von Willebrand disease.
de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, Leebeek FW; Win Study Group. de Wee EM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2010 Jul;8(7):1492-9. doi: 10.1111/j.1538-7836.2010.03864.x. Epub 2010 Mar 23. J Thromb Haemost. 2010. PMID: 20345712 Free article.
Impact of von Willebrand disease on health-related quality of life in a pediatric population.
de Wee EM, Fijnvandraat K, de Goede-Bolder A, Mauser-Bunschoten EP, Eikenboom JC, Brons PP, Smiers FJ, Tamminga R, Oostenbrink R, Raat H, van der Bom JG, Leebeek FW; WiN Study Group. de Wee EM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2011 Mar;9(3):502-9. doi: 10.1111/j.1538-7836.2010.04175.x. J Thromb Haemost. 2011. PMID: 21166992 Free article.
Surgery and inhibitor development in hemophilia A: a systematic review.
Eckhardt CL, van der Bom JG, van der Naald M, Peters M, Kamphuisen PW, Fijnvandraat K. Eckhardt CL, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2011 Oct;9(10):1948-58. doi: 10.1111/j.1538-7836.2011.04467.x. J Thromb Haemost. 2011. PMID: 21838755 Free article. Review.
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM, Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW; WiN Study Group. De Wee EM, et al. Among authors: fijnvandraat k. Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.
De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW; WiN study group. De Wee EM, et al. Among authors: fijnvandraat k. Thromb Haemost. 2011 Nov;106(5):885-92. doi: 10.1160/TH11-03-0180. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21947221
Neonatal bleeding in haemophilia: a European cohort study.
Richards M, Lavigne Lissalde G, Combescure C, Batorova A, Dolan G, Fischer K, Klamroth R, Lambert T, Lopez-Fernandez M, Pérez R, Rocino A, Fijnvandraat K; European Haemophilia Treatment and Standardization Board. Richards M, et al. Among authors: fijnvandraat k. Br J Haematol. 2012 Feb;156(3):374-82. doi: 10.1111/j.1365-2141.2011.08967.x. Epub 2011 Dec 7. Br J Haematol. 2012. PMID: 22146054 Free article.
222 results